Mechanisms of disease: atherosclerosis in autoimmune diseases. - Wikidata - awgldk - TriplyDB

Mechanisms of disease: atherosclerosis in autoimmune diseases.

Mechanisms of disease: atherosclerosis in autoimmune diseases.

http://www.wikidata.org/entity/Q36577423

about

MPNs as Inflammatory Diseases: The Evidence, Consequences, and Perspectives "How many times must a man look up before he can really see the sky?" Rheumatic cardiovascular disease in the era of multimodality imaging.The Sphinx's riddle: cardiovascular involvement in autoimmune rheumatic disease Cholesterol, inflammation and innate immunity A critical view on cardiovascular risk in systemic sclerosis.Contribution of vascular cell-derived cytokines to innate and inflammatory pathways in atherogenesis.Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Anti-apolipoprotein A-1 IgG as an independent cardiovascular prognostic marker affecting basal heart rate in myocardial infarction.Tetrahydrobiopterin in cardiovascular health and disease.Risk of stroke in patients with rheumatism: a nationwide longitudinal population-based study.Immunomodulation of vascular diseases: atherosclerosis and autoimmunity Cardiovascular disease in immune-mediated inflammatory diseases: A cross-sectional analysis of 6 cohorts Endothelial cell markers reflecting endothelial cell dysfunction in patients with mixed connective tissue disease.Cardiovascular involvement in autoimmune diseases.Antigen-specific immune reactions to ischemic stroke.Immunomodulation with eicosapentaenoic acid supports the treatment of autoimmune small-vessel vasculitis.Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.Lipid profile and metabolic syndrome status in patients with oral lichen planus, oral lichenoid reaction and healthy individuals attending a dental college in northern India - a descriptive study Jeremiah Metzger Lecture: cholesterol, inflammation and atherosclerotic cardiovascular disease: is it all LDL?Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity.The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations.A clinical approach to inherited premature coronary artery disease Accelerated vascular disease in systemic lupus erythematosus: role of macrophage.Antigenic challenge in the etiology of autoimmune disease in women Mortality in Rheumatoid Arthritis (RA): factors associated with recording RA on death certificates.Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis Immunoactivation at the crossroads of human disease LDLR and PCSK9 Are Associated with the Presence of Antiphospholipid Antibodies and the Development of Thrombosis in aPLA Carriers Heart disease is common in humans and chimpanzees, but is caused by different pathological processes.Nature and nurture in atherosclerosis: The roles of acylcarnitine and cell membrane-fatty acid intermediates.Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target Cardiovascular co-morbidity in rheumatic diseases.Assessment of blood clot formation and platelet receptor function ex vivo in patients with primary Sjogren's syndrome.Accelerated atherosclerosis in rheumatoid arthritis.Altered lipoprotein metabolism in chronic inflammatory states: proinflammatory high-density lipoprotein and accelerated atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis Vascular involvement in rheumatic diseases: 'vascular rheumatology'.High density lipoprotein biogenesis, cholesterol efflux, and immune cell function.

P2860

Q26775996-22870AB7-E152-4994-BF9A-8E47DF590C41 Q26785666-2DB4F93F-46B1-4604-99E9-68DABE9F19B2 Q28069667-8002EF63-6387-4630-9235-0926B9FD35A3 Q28086912-5A38C83F-2CD2-42CC-B612-122A0451AF93 Q30249024-57E50A4C-19CB-4B69-ABA2-738A5619C8E4 Q30318502-89181695-4453-44A0-A750-87AF5AC5E5BB Q30319434-E476AFC0-3D72-4CF6-9F3A-6AA74897744E Q33533540-7E71ECF3-5AE8-42CE-ADF8-CADE20BDAAD6 Q33687812-75B467B3-FF95-492A-9740-C69975727C60 Q33714074-8B1EB78C-5774-48AA-A701-9E13FFA2EC6B Q33770999-EE432B69-CBA8-4100-88B4-264206300328 Q33879759-FFCED428-98F7-4B88-A8D5-7EFB60659446 Q34027430-F1345A9B-7812-4CEE-B363-6500657D440C Q34081242-1BA29085-0B04-42D5-B939-F064DF65FA31 Q34171339-7BBB691C-9E39-4C4C-893B-30299255CE0D Q34201979-C79105AA-580D-4634-B5BF-708DB2B99927 Q34440352-DAA0F4A9-26BE-4062-A158-1D40FBD49082 Q34482096-751709E5-E50F-40F5-BEBD-989DFB775D64 Q34910792-FD8C504F-8A3D-4C68-8B37-A9017DB5131C Q35049058-B3AE2E11-C0D8-4470-95D7-24102884FB4A Q35214718-ECB8259E-48C1-4D74-B5A4-6FDB4ECBCB15 Q35234169-CBF451BA-2CD7-4233-9C6F-082B4E688934 Q35387131-562AD680-A9EA-437D-B411-2FAA6D64500F Q35490637-04910452-DE3D-427C-9307-2D0970C7C1E4 Q35539166-119F409A-BBBF-440E-83A1-AFBAB32C46E7 Q35622496-14B1C87B-47DE-4DD2-BA96-DDE33A2C05E1 Q35800079-B8270EE0-00EF-4C93-8909-797040E44DBB Q35868721-3F92EF57-B701-4167-A23D-36FD5374678E Q35897390-77690DBD-8D40-43CA-A158-E853B8A6EFF5 Q35907083-29523AE4-EB8E-4DB5-A573-05CB9DC2097F Q35960796-2758E771-5FA9-43E7-A5F7-C93681F7E6BB Q36418591-18A4D687-69CC-497B-A571-57E1B557C130 Q36596375-8B469DCA-8CF8-4FB0-B802-2EDA483437BF Q36708991-0582222B-9C6F-471B-8024-317B838B656A Q36835851-870B367C-C9BB-414B-8AF7-EA1CD0E511A2 Q36889466-619EC830-F81F-4E03-A76B-AEB13DE9173C Q36951047-3EC88BC5-61F4-4A46-9F7C-086483823330 Q36955395-E4F12B72-AFD8-4AAB-A8C3-B2FD98139890 Q36993260-3C48D71F-A670-453D-B76D-1252E95FE87D Q37221779-C6577FED-9F69-4E95-B288-53486F9DC262

P2860

Mechanisms of disease: atherosclerosis in autoimmune diseases.

http://www.wikidata.org/entity/Q36577423

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Mechanisms of disease: atherosclerosis in autoimmune diseases.

@ast

Mechanisms of disease: atherosclerosis in autoimmune diseases.

@en

type

label

Mechanisms of disease: atherosclerosis in autoimmune diseases.

@ast

Mechanisms of disease: atherosclerosis in autoimmune diseases.

@en

prefLabel

Mechanisms of disease: atherosclerosis in autoimmune diseases.

@ast

Mechanisms of disease: atherosclerosis in autoimmune diseases.

@en

P1433

Q36577423-B2B2249D-65FF-4F68-A60C-FA76327CAE10

P1476

Q36577423-291CB0F3-63AC-417D-A067-4B78EBFA5147

P2860

Q36577423-03A44850-F572-4A36-80D2-CA466903AE54

Q36577423-09DAACCF-5E9E-4EE7-8522-D8A698E1A2D1

Q36577423-0B00C26F-FA42-40C9-94C8-ACE0D0648A88

Q36577423-0E78E8EC-8C26-428E-8B6A-6026D7F134DF

Q36577423-16A9E9CB-E5E5-4E7C-AA41-15B071F52814

Q36577423-1DBAE46F-5C73-4171-8416-33EC1C9BACF5

Q36577423-36C86B93-3BAE-43F7-884E-73E45FB2B5D0

Q36577423-371D7F90-F70E-4638-9728-CBC29728667A

Q36577423-426A4972-FD36-4806-84A9-F8E6F857001D

Q36577423-4271610A-24B5-4E8E-BF00-6FE508BB8DD4

P304

Q36577423-0C89CC0F-E214-4580-A871-FD9B434B621D

P31

Q36577423-D2673D8C-CB5D-4928-A050-C8CF7A8EEA53

P356

Q36577423-0DD390E6-962B-4A97-BFCF-373D14FFC9FE

P433

Q36577423-AEBA3C1B-89B9-4CAA-8EAE-9B12F586D7C6

P478

Q36577423-215968BB-2E71-44AC-9D6F-DFA7C5E3A777

P50

Q36577423-49467D93-6A7C-4C4A-8EBE-ED52EAEE571B

Q36577423-D41B4026-222C-4918-9CD7-C9F4722F260F

P577

Q36577423-F63B27C1-E7FE-48A1-B190-0C8B9D04F833

P5875

Q36577423-C55291B2-88A7-4E39-A50F-140FC3DAB8AD

P698

Q36577423-A06ECB0B-37C7-41A8-B0B2-F0CF8485BDB3

P921

Q36577423-7FAC1D37-AD77-4760-A3BE-09BBDBA29D74

P356

P1433

Nature Clinical Practice Rheumatology

P1476

Mechanisms of disease: atherosclerosis in autoimmune diseases.

@en

P2860

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

Inflammation, atherosclerosis, and coronary artery disease

Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data.

Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease.

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

Immunomodulation for treatment and prevention of atherosclerosis.

Immunomodulation of various autoimmune diseases by intravenous immunoglobulin.

Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus

P304

99-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NCPRHEUM0092

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Yehuda Shoenfeld

P577

2006-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6855131

http://www.w3.org/2001/XMLSchema#string

P698

16932663

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis